ADHD Trial, Recruiting NCT07504107 Sponsor: Universiteit Leiden Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT07504107
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 16 and 25 years old.
  • You have an official ADHD diagnosis, which the research team will confirm using a structured clinical interview.
  • You have low self-esteem related to your ADHD, which is checked through a step-by-step process: a referral from a clinician, a short phone screening with two questions about how you feel about yourself, and a more detailed assessment at your first appointment using a questionnaire and a conversation with a trained researcher.
  • If you take medication for ADHD, your dose must have been stable for at least 4 weeks before joining the trial (changes during the study are not preferred but will be carefully recorded if they happen).

Who may not be able to join:

  • You have a serious mental health condition that needs immediate treatment, such as severe depression or thoughts of suicide (as decided by your therapist and/or the research team).
  • You are currently receiving any psychological treatment or therapy, including therapy specifically for ADHD — therapy or education completed before the study is fine, but not during it.
  • Your low self-esteem is directly caused by a traumatic experience, which would mean a different type of treatment is more appropriate (this is assessed by your referring therapist).
  • Your IQ is below 80, as measured by two specific sections of a standard intelligence test.
  • You have a serious problem with substance use, as determined by your therapist and/or the research team.
  • You have a confirmed diagnosis of Autism Spectrum Disorder (ASD), or your referring therapist believes an ASD diagnosis is very likely, even if it has not been officially confirmed yet.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31 71 5272727

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universiteit Leiden
Registry
ClinicalTrials.gov
Start date
25 March 2026
Est. completion
31 March 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Self-Esteem (Rosenberg Self-Esteem Scale; RSES)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov